Andrew K. Godwin
Affiliations: | Biochemistry and Molecular Biology | Drexel University College of Medicine, Philadelphia, PA, United States |
Area:
Molecular Biology, Biostatistics BiologyGoogle:
"Andrew Godwin"Parents
Sign in to add mentor| Thomas C. Hamilton | grad student | Penn | |
| Robert F. Orzols | grad student | Penn |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| de Santiago PR, Sato S, Zhang SJ, et al. (2025) LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker. Npj Precision Oncology. 9: 62 |
| Madan E, Palma AM, Vudatha V, et al. (2024) Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells. Nature Biotechnology |
| Gupta VG, Hirst J, Petersen S, et al. (2021) Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer. Gynecologic Oncology |
| Kim O, Park EY, Kwon SY, et al. (2020) Targeting progesterone signaling prevents metastatic ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America |
| Rose IM, Bidarimath M, Webster A, et al. (2020) WNT and inflammatory signaling distinguish human Fallopian tube epithelial cell populations. Scientific Reports. 10: 9837 |
| Zhang H, Ahearn TU, Lecarpentier J, et al. (2020) Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics |
| Trinidad CV, Tetlow AL, Bantis LE, et al. (2020) Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers. Cancer Prevention Research (Philadelphia, Pa.). 13: 241-252 |
| Telfah M, Iwakuma T, Bur A, et al. (2019) A window of opportunity trial of atorvastatin in p53-mutant and p53 wild type malignancies. Journal of Clinical Oncology. 37 |
| Lu Y, Beeghly-Fadiel A, Wu L, et al. (2018) A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research |
| Hirst J, Pathak HB, Hyter S, et al. (2018) Licofelone enhances the efficacy of paclitaxel in ovarian cancer by reversing drug resistance and tumor stem-like properties. Cancer Research |